Trade Summary

3 months ago, Debbane Raymond, serving as Dir at Lexicon Pharmaceuticals, Inc. (LXRX), purchased 150,000 shares at $1.47 per share, for a total transaction value of $219,755.00. Following this transaction, Debbane Raymond now holds 51,558,909 shares of LXRX.

The trade was executed on Thursday, February 19, 2026 and publicly disclosed via SEC Form 4 filing on Monday, February 23, 2026 at 7:49 AM ET, 4 days after the trade was made.

Lexicon Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.